BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26440526)

  • 1. Exponential increase of glutamic acid decarboxylase (GAD) antibody titer after initiating and stopping insulin in a patient with slowly progressive type 1 diabetes.
    Nishimura A; Nagasawa K; Okubo M; Kobayashi T; Mori Y
    Endocr J; 2015; 62(12):1077-82. PubMed ID: 26440526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
    Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
    PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
    Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
    Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Maruyama T; Tanaka S; Shimada A; Funae O; Kasuga A; Kanatsuka A; Takei I; Yamada S; Harii N; Shimura H; Kobayashi T
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2115-21. PubMed ID: 18397986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
    Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
    Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characteristics of GAD-antibody positive patients initially diagnosed as having type 2 diabetes.
    Hamaguchi K; Kimura A; Kusuda Y; Yamashita T; Yasunami M; Takahasi M; Abe N; Yoshimatsu H
    Diabetes Res Clin Pract; 2004 Nov; 66(2):163-71. PubMed ID: 15533584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes.
    Yabuki S; Hirai H; Moriya C; Kusano Y; Hasegawa T
    Front Endocrinol (Lausanne); 2024; 15():1407192. PubMed ID: 38841300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
    Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
    Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M; Pes GM; Delitala G; Puddu L; Falorni A; Tolu F; Lampis R; Orrù V; Secchi G; Cicalò AM; Floris R; Madau GF; Pilosu RM; Whalen M; Cucca F
    Eur J Endocrinol; 2010 Oct; 163(4):541-9. PubMed ID: 20603341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
    Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
    J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus.
    Kobayashi T; Maruyama T; Shimada A; Kasuga A; Kanatsuka A; Takei I; Tanaka S; Yokoyama J
    Ann N Y Acad Sci; 2002 Apr; 958():117-30. PubMed ID: 12021091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowly progressive type 1 diabetes treated with metformin for five years after onset.
    Hirata T; Shimada A; Morimoto J; Maruyama T
    Intern Med; 2013; 52(23):2635-7. PubMed ID: 24292754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
    Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
    Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
    Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
    Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II is associated with the frequency of glutamic acid decarboxylase M(r) 65,000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus.
    Kasuga A; Falorni A; Maruyama T; Ozawa Y; Grubin CE; Matsubara K; Takei I; Saruta T; Scheynius A; Lernmark A
    Acta Diabetol; 1996 Jul; 33(2):108-13. PubMed ID: 8870811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies.
    Obayashi H; Hasegawa G; Fukui M; Kamiuchi K; Kitamura A; Ogata M; Kanaitsuka T; Shigeta H; Kitagawa Y; Nakano K; Nishimura M; Ohta M; Nakamura N
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3348-51. PubMed ID: 10999832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slowly progressive insulin-dependent (type 1) diabetes positive for anti-GAD antibody ELISA test may be strongly associated with a future insulin-dependent state.
    Oikawa Y; Tanaka H; Uchida J; Atsumi Y; Osawa M; Katsuki T; Kawai T; Shimada A
    Endocr J; 2017 Feb; 64(2):163-170. PubMed ID: 27760891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.